Fact Check: Viral posts misuse VAERS data to make false claims about COVID-19 vaccines Share Updated: 5:40 PM PDT Apr 8, 2021 By Catalina Jaramillo, FactCheck.org
TRACKING THE COVID-19 VACCINE Share Updated: 5:40 PM PDT Apr 8, 2021 By Catalina Jaramillo, FactCheck.org Posted on March 31, 2021; Leer en españolWe are collaborating with FactCheck.org, a project of the Annenberg Public Policy Center of the University of Pennsylvania, in an effort to identify misinformation and to ensure news consumers get the facts. This story first appeared on FactCheck.org.SciCheck DigestSocial media posts repeatedly misuse unverified data from the Vaccine Adverse Event Reporting System to falsely claim that COVID-19 vaccines are dangerous, and even lethal. But the government database is not designed to determine if vaccines cause health problems.Full StoryMillions of people in the United States have safely received COVID-19 vaccines. Over 145 million doses h
Instagram Post Misrepresents FDA Document About Monitoring Vaccine Safety
factcheck.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from factcheck.org Daily Mail and Mail on Sunday newspapers.
Britain's medical regulator on Thursday said it would fast-track vaccines for coronavirus variants, adding that the makers of already-authorised shots would not need new lengthy clinical trials to prove their adapted vaccines will work. There is concern that some variants, such as those first found in South Africa and Brazil, may reduce the efficacy of the first generation of COVID-19 vaccines, and manufacturers are looking to adapt their shots. The accelerated process is based on that used for seasonal flu vaccines each year, the Medicines & Healthcare products Regulatory Agency (MHRA) said, and would be based on robust evidence that the shots create an immune response, rather than full clinical trials.
/Middle East and Africa Typhoid Fever Vaccines Market is expected to Rise to US$ US$ 37.09 by 2027
Middle East and Africa Typhoid Fever Vaccines Market is expected to Rise to US$ US$ 37.09 by 2027
Middle East and Africa typhoid fever vaccines market is expected to reach US$ US$ 37.09 million in 2027 from US$ 20.00 million in 2019. The market is estimated to grow with a CAGR of 8.3% from 2020-2027.
tipFebruary 25, 2021 4
Middle East and Africa typhoid fever vaccines market is expected to reach US$ US$ 37.09 million in 2027 from US$ 20.00 million in 2019. The market is estimated to grow with a CAGR of 8.3% from 2020-2027. Factors such as growing initiatives for typhoid fever in Middle East and Africa region and the key factor contributing to the growth of the market. On the other hand, the market is likely to have negative impact due to risk of associated with typhoid fever vaccines.
Developers for COVID-19 therapeutics, vaccines and testing do not need to conduct large and lengthy clinical trials to address new coronavirus variants, new guidance from the Food and Drug Administration said Monday. Why it matters: Mutated versions of the coronavirus threaten to prolong the pandemic, possibly for years to come — especially if current treatments are rendered less effective. The FDA's updated recommendations could greatly accelerate the emergency authorization process to address these concerns.Stay on top of the latest market trends and economic insights with Axios Markets. Subscribe for freeThe state of play: The vaccines authorized by the FDA — produced by Moderna and Pfizer-BioNTech — have still been found to be effective against the new variants, but both companies have announced plans to modify their vaccines to better protect against mutations.Any adjustments developers make for new variants would need small trials, like those required fo
vimarsana © 2020. All Rights Reserved.